CX Institutional’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
1,160
-1,350
| -54% | -$123K | ﹤0.01% | 758 |
|
|
2025
Q1 | $284K | Buy |
2,510
+174
| +7% | +$19.7K | 0.01% | 495 |
|
|
2024
Q4 | $247K | Buy |
2,336
+1,477
| +172% | +$156K | 0.01% | 475 |
|
|
2024
Q3 | $92.7K | Buy |
+859
| New | +$92.7K | ﹤0.01% | 550 |
|
|
2024
Q2 | – | Sell |
-2,109
| Closed | -$278K | – | 571 |
|
|
2024
Q1 | $278K | Buy |
2,109
+119
| +6% | +$15.7K | 0.01% | 476 |
|
|
2023
Q4 | $242K | Buy |
+1,990
| New | +$242K | 0.01% | 452 |
|
|
2023
Q3 | – | Sell |
-1,622
| Closed | -$236K | – | 560 |
|
|
2023
Q2 | $236K | Buy |
+1,622
| New | +$236K | 0.01% | 474 |
|
|
2022
Q3 | – | Sell |
-747
| Closed | -$79K | – | 1149 |
|
|
2022
Q2 | $79K | Buy |
+747
| New | +$79K | 0.01% | 590 |
|
|
2021
Q4 | – | Sell |
-473
| Closed | -$67K | – | 922 |
|
|
2021
Q3 | $67K | Buy |
473
+105
| +29% | +$14.9K | 0.01% | 529 |
|
|
2021
Q2 | $57K | Buy |
368
+81
| +28% | +$12.5K | ﹤0.01% | 543 |
|
|
2021
Q1 | $45K | Buy |
287
+57
| +25% | +$8.94K | ﹤0.01% | 513 |
|
|
2020
Q4 | $34K | Buy |
230
+112
| +95% | +$16.6K | ﹤0.01% | 508 |
|
|
2020
Q3 | $16K | Buy |
118
+15
| +15% | +$2.03K | ﹤0.01% | 597 |
|
|
2020
Q2 | $12K | Buy |
103
+75
| +268% | +$8.74K | ﹤0.01% | 539 |
|
|
2020
Q1 | $3K | Sell |
28
-28
| -50% | -$3K | ﹤0.01% | 641 |
|
|
2019
Q4 | $8K | Hold |
56
| – | – | ﹤0.01% | 479 |
|
|
2019
Q3 | $7K | Buy |
56
+10
| +22% | +$1.25K | ﹤0.01% | 527 |
|
|
2019
Q2 | $5K | Sell |
46
-1
| -2% | -$109 | ﹤0.01% | 626 |
|
|
2019
Q1 | $6K | Buy |
+47
| New | +$6K | ﹤0.01% | 531 |
|